S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis
Molecular Immunology · 2023-08 · 160 · 55-66
DOI: 10.1016/j.molimm.2023.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2023-08. Verfasst von Jihua Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: jihuatian429@163.com. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Nephritis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, Shanxi Medical University, Shanxi Province Science and Technology Department.
Abstract (Originalsprache)
Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE) as well as the leading cause of mortality in patients. Previous studies revealed that S1P level is elevated in plasma samples of SLE patients and murine lupus models. FTY720, targeting S1P receptors, exhibited therapeutic effects in improving the nephritis symptoms of lupus mouse models. However, few studies have discussed the potential relevance of S1P/S1PR to the pathogenesis of LN. Macrophages have been shown to be an important causative agent of renal inflammation, while the pro-inflammatory M1-type promotes kidney injury and inflammation during LN. Importantly, macrophages express various S1P receptors, and how they respond to S1P in the setting of LN remains unclear. Therefore, we examined the level of S1P in the lupus MRL/lpr mice and explored the ensuing interaction of macrophages and S1P. We found that S1P level was elevated in the MRL/lpr mice with a subsequent enhancement of the S1PR1 expression, and blocking S1PR1 by FTY720, the nephritis symptoms of MRL/lpr mice were improved. Mechanistically, we demonstrated that elevated S1P level increase the M1-type macrophage accumulation. And the in-vitro studies proved that S1P/S1PR1 was involved in the promotion of macrophage polarization towards M1 type through activation of NLRP3 inflammasome. These findings confer a novel role to macrophage S1PR1 and provide a new perspective for targeting S1P during LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: jihuatian429@163.com.
- Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: weipingf@sxmu.edu.cn.
- Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: wangyanhongmail@126.com.
Förderung
- Natural Science Foundation of Shanxi Province
- Shanxi Medical University
- Shanxi Province Science and Technology Department
- Shanxi Provincial Education Department
- National Natural Science Foundation of China
- Shanxi Scholarship Council of China
Zitieren
APA
Tian, J., Chang, S., Wang, J., Chen, J., Xu, H., Huang, T., Wang, J., Kang, J., Fan, W., & Wang, Y. (2023). S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis. Molecular Immunology, 160, 55-66. https://doi.org/10.1016/j.molimm.2023.06.006
Vancouver
Tian J, Chang S, Wang J, Chen J, Xu H, Huang T, et al. S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis. Molecular Immunology. 2023;160:55-66. doi:10.1016/j.molimm.2023.06.006
BibTeX
@article{Tian2023,
author = {Tian, Jihua and Chang, Sijia and Wang, Jing and Chen, Jingshu and Xu, Huanyu and Huang, Taiping and Wang, Juanjuan and Kang, Jing and Fan, Weiping and Wang, Yanhong},
title = {S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis},
journal = {Molecular Immunology},
year = {2023},
volume = {160},
pages = {55--66},
doi = {10.1016/j.molimm.2023.06.006}
}
EUVIMED